Andreas Viardot

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Hematological oncology

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, Kamal Bouabdallah, Mathieu Leclerc, Guillaume Cartron, Pascal Turlure, Peter Reimer, Eva Maria Wagner-Drouet, Laurence Sanhes, Houot Roch, Murielle Roussel, Frank Kroschinsky, Peter Dreger, Andreas Viardot, Laurence L de Leval, Andreas Rosenwald, Philippe Gaulard, Gerald Georg Wulf, Alban Villate, Christelle Latiere, Ahmet Elmaagacli, Bertram Glass, Viola Poeschel, Gandhi Laurent Damaj, David Sibon, Eric Durot, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Ulrich Bernd Keller, Mourad Tiab, Bernard Drénou, Jérome Cornillon, Stéphanie Nguyen, Marie Robin, Maike Nickelsen, Lorenz Trümper, Georg Lenz, Marita Ziepert, Norbert Schmitz, null null, null null, null null, null null
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sarah Bailly, Guillaume Cartron, Sridhar Chaganti, Raul Cordoba, Paolo Corradini, Johannes Düll, Isacco Ferrarini, Wendy Osborne, Andreas Rosenwald, Juan-Manuel Sancho, Herve Tilly, Eric Van Den Neste, Andreas Viardot, Chiara Rusconi
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper. Hematological oncology 40 (4) (2022)
Deborah A Katz, Joan D Morris, Michael P Chu, Kevin A David, Catherine Thieblemont, Nicholas J Morley, Sharif S Khan, Andreas Viardot, Alejandro Martín García-Sancho, Guillermo Rodríguez-García, Mariana Bastos-Oreiro, Seung Tae Lee, William Kormany, Yuqi Chen, Hansen L Wong, Abraham A Anderson, Yuliya Katlinskaya, Ariel A Avilion, Tian Dai, Eva González-Barca
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL. Leukemia & lymphoma 63 (9) (2022)
Alexander Grunenberg, Elisa Sala, Silke Kapp-Schwoerer, Andreas Viardot
Pharmacotherapeutic management of T-cell acute lymphoblastic leukemia in adults: an update of the literature. Expert opinion on pharmacotherapy 23 (5) (2022)
Dominic Kaddu-Mulindwa, Vadim Lesan, Christian Berdel, Stephan Stilgenbauer, Moritz Bewarder, Lorenz Thurner, Mathias Witzens-Harig, Andreas Viardot, Martin Soekler, Ulrich Keller, Lorenz Truemper, Konstantinos Christofyllakis, Octavian Fleser, Joerg Thomas Bittenbring, Viola Poeschel, Gerhard Held, Philippe Jagoda
Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Leukemia & lymphoma (2021)
Andreas Viardot, Elisa Sala
Investigational immunotherapy targeting CD19 for the treatment of acute lymphoblastic leukemia. Expert opinion on investigational drugs 30 (7) (2021)
Nina D Wagner-Johnston, Stephen J Schuster, Sven deVos, Gilles Salles, Wojciech J Jurczak, Christopher R Flowers, Andreas Viardot, Ian W Flinn, Peter Martin, Guan Xing, Nishanthan Rajakumaraswamy, Ajay K Gopal
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas. Leukemia & lymphoma 62 (5) (2020)
Andreas Viardot, Georg Hess, Ralf C Bargou, Nicholas J Morley, Giuseppe Gritti, Maria-Elisabeth Goebeler, Karim Iskander, David Cohan, Alicia Zhang, Janet Franklin, Luke Coyle
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma. Leukemia & lymphoma 61 (11) (2020)

Andreas Viardot.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Viardot